A vaccine trial in the United States is revealing promising early information, after the vaccine apparently produced protective antibodies in a little group of healthy volunteers. 8 people took part in the safety trial by Moderna, which began in March, and the vaccine was revealed to be safe while all individuals produced antibodies, the biotech […]

The post Coronavirus: US vaccine trial shows promising early results, biotech firm says appeared first on World Weekly News.